RxDoctor Payments Data

Brittany Martin

Family · Trafalgar, INNPI 1376195578

Payments from drug & device makers

$1,642in general payments, 2019–2025

Across 82 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$376
  • Lilly USA, LLC$251
  • Novo Nordisk$164
  • Exact Sciences$144
  • Ironshore Pharmaceuticals Inc.$72
  • Amgen$65
  • plus $569 from 18 others

What the payments were for

  • Food & beverage$1,642100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,642 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$72,734
JardianceEmpagliflozin28$44,861
MounjaroTirzepatide30$37,252
TrulicityDulaglutide22$29,907
EliquisApixaban16$25,121
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$20,654
FarxigaDapagliflozin Propanediol15$18,461
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$17,075
Spiriva RespimatTiotropium Bromide24$16,381
Breo ElliptaFluticasone/Vilanterol22$11,674
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$6,236
Humalog Kwikpen U-100Insulin Lispro14$5,115
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen115$2,607
Albuterol Sulfate HfaAlbuterol Sulfate100$2,045
Celecoxib13$1,379

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$164$72,73444 claims
Lilly USA, LLCMounjaro, Trulicity$251$67,15952 claims
AstraZenecaFarxiga, Breztri Aerosphere$48$35,53636 claims
GSKTrelegy Ellipta, Breo Ellipta$64$32,32844 claims
PfizerEliquis$49$25,12116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.

Other family in Trafalgar

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →